A carregar...
Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
Aberrant regulation of angiogenesis involves in the growth and metastasis of tumors, but angiogenesis inhibitors fail to improve overall survival of pancreatic cancer patients in previous phase III clinical trials. A comprehensive knowledge of the mechanism of angiogenesis inhibitors against pancrea...
Na minha lista:
| Publicado no: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969999/ https://ncbi.nlm.nih.gov/pubmed/33748143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.649265 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|